Logo image of CRDO

CREDO TECHNOLOGY GROUP HOLDI (CRDO) Stock Fundamental Analysis

NASDAQ:CRDO - Nasdaq - KYG254571055 - Common Stock - Currency: USD

60.96  -2.87 (-4.5%)

Premarket: 60.89 -0.07 (-0.11%)

Fundamental Rating

5

Overall CRDO gets a fundamental rating of 5 out of 10. We evaluated CRDO against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. While CRDO has a great health rating, there are worries on its profitability. CRDO shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CRDO was profitable.
In the past year CRDO had a positive cash flow from operations.
In the past 5 years CRDO always reported negative net income.
CRDO had negative operating cash flow in 4 of the past 5 years.
CRDO Yearly Net Income VS EBIT VS OCF VS FCFCRDO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

CRDO has a Return On Assets (0.71%) which is comparable to the rest of the industry.
CRDO's Return On Equity of 0.83% is in line compared to the rest of the industry. CRDO outperforms 47.27% of its industry peers.
Industry RankSector Rank
ROA 0.71%
ROE 0.83%
ROIC N/A
ROA(3y)-4.92%
ROA(5y)-6.49%
ROE(3y)-5.55%
ROE(5y)-7.19%
ROIC(3y)N/A
ROIC(5y)N/A
CRDO Yearly ROA, ROE, ROICCRDO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -5 -10 -15

1.3 Margins

With a Profit Margin value of 1.56%, CRDO perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
CRDO has a better Gross Margin (63.72%) than 90.00% of its industry peers.
In the last couple of years the Gross Margin of CRDO has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 1.56%
GM 63.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.74%
GM growth 5YN/A
CRDO Yearly Profit, Operating, Gross MarginsCRDO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

More info and screens

8

2. Health

2.1 Basic Checks

CRDO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CRDO has been increased compared to 1 year ago.
There is no outstanding debt for CRDO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CRDO Yearly Shares OutstandingCRDO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M
CRDO Yearly Total Debt VS Total AssetsCRDO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

CRDO has an Altman-Z score of 62.18. This indicates that CRDO is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 62.18, CRDO belongs to the top of the industry, outperforming 98.18% of the companies in the same industry.
CRDO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 62.18
ROIC/WACCN/A
WACC11.11%
CRDO Yearly LT Debt VS Equity VS FCFCRDO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

CRDO has a Current Ratio of 7.67. This indicates that CRDO is financially healthy and has no problem in meeting its short term obligations.
CRDO's Current ratio of 7.67 is amongst the best of the industry. CRDO outperforms 90.00% of its industry peers.
CRDO has a Quick Ratio of 7.01. This indicates that CRDO is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 7.01, CRDO belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.67
Quick Ratio 7.01
CRDO Yearly Current Assets VS Current LiabilitesCRDO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

8

3. Growth

3.1 Past

CRDO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 2250.00%, which is quite impressive.
The Revenue has grown by 99.37% in the past year. This is a very strong growth!
CRDO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 48.69% yearly.
EPS 1Y (TTM)2250%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%525%
Revenue 1Y (TTM)99.37%
Revenue growth 3Y48.69%
Revenue growth 5YN/A
Sales Q2Q%154.44%

3.2 Future

CRDO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 113.11% yearly.
Based on estimates for the next years, CRDO will show a very strong growth in Revenue. The Revenue will grow by 48.09% on average per year.
EPS Next Y619.1%
EPS Next 2Y260.17%
EPS Next 3Y163.01%
EPS Next 5Y113.11%
Revenue Next Year121.6%
Revenue Next 2Y87.6%
Revenue Next 3Y64.53%
Revenue Next 5Y48.09%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CRDO Yearly Revenue VS EstimatesCRDO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
CRDO Yearly EPS VS EstimatesCRDO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0 0.5 1 1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 141.77, which means the current valuation is very expensive for CRDO.
60.91% of the companies in the same industry are cheaper than CRDO, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.25, CRDO is valued quite expensively.
CRDO is valuated quite expensively with a Price/Forward Earnings ratio of 52.21.
CRDO's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CRDO is more expensive than 63.64% of the companies in the same industry.
CRDO's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.15.
Industry RankSector Rank
PE 141.77
Fwd PE 52.21
CRDO Price Earnings VS Forward Price EarningsCRDO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CRDO.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 697.24
CRDO Per share dataCRDO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

CRDO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CRDO's earnings are expected to grow with 163.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y260.17%
EPS Next 3Y163.01%

More info and screens

0

5. Dividend

5.1 Amount

CRDO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CREDO TECHNOLOGY GROUP HOLDI

NASDAQ:CRDO (5/30/2025, 8:00:00 PM)

Premarket: 60.89 -0.07 (-0.11%)

60.96

-2.87 (-4.5%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)03-04 2025-03-04/amc
Earnings (Next)06-02 2025-06-02/amc
Inst Owners76.59%
Inst Owner ChangeN/A
Ins Owners15.4%
Ins Owner Change-2.05%
Market Cap10.35B
Analysts83.16
Price Target67.42 (10.6%)
Short Float %7.1%
Short Ratio1.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)31.55%
Min EPS beat(2)29.49%
Max EPS beat(2)33.61%
EPS beat(4)3
Avg EPS beat(4)22.81%
Min EPS beat(4)-4.12%
Max EPS beat(4)33.61%
EPS beat(8)6
Avg EPS beat(8)77.96%
EPS beat(12)9
Avg EPS beat(12)187.46%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.99%
Min Revenue beat(2)5.74%
Max Revenue beat(2)10.24%
Revenue beat(4)2
Avg Revenue beat(4)3.11%
Min Revenue beat(4)-1.85%
Max Revenue beat(4)10.24%
Revenue beat(8)5
Avg Revenue beat(8)1.95%
Revenue beat(12)6
Avg Revenue beat(12)1.15%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.49%
PT rev (3m)-17.66%
EPS NQ rev (1m)0%
EPS NQ rev (3m)23.33%
EPS NY rev (1m)0%
EPS NY rev (3m)23.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)16.6%
Revenue NY rev (1m)0%
Revenue NY rev (3m)9.5%
Valuation
Industry RankSector Rank
PE 141.77
Fwd PE 52.21
P/S 31.6
P/FCF N/A
P/OCF 906.55
P/B 16.74
P/tB 16.74
EV/EBITDA 697.24
EPS(TTM)0.43
EY0.71%
EPS(NY)1.17
Fwd EY1.92%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)0.07
OCFY0.11%
SpS1.93
BVpS3.64
TBVpS3.64
PEG (NY)0.23
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.71%
ROE 0.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.56%
GM 63.72%
FCFM N/A
ROA(3y)-4.92%
ROA(5y)-6.49%
ROE(3y)-5.55%
ROE(5y)-7.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.74%
GM growth 5YN/A
F-Score7
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 198.15%
Cap/Sales 10.87%
Interest Coverage N/A
Cash Conversion 80.48%
Profit Quality N/A
Current Ratio 7.67
Quick Ratio 7.01
Altman-Z 62.18
F-Score7
WACC11.11%
ROIC/WACCN/A
Cap/Depr(3y)236.32%
Cap/Depr(5y)293.96%
Cap/Sales(3y)12.13%
Cap/Sales(5y)12.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2250%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%525%
EPS Next Y619.1%
EPS Next 2Y260.17%
EPS Next 3Y163.01%
EPS Next 5Y113.11%
Revenue 1Y (TTM)99.37%
Revenue growth 3Y48.69%
Revenue growth 5YN/A
Sales Q2Q%154.44%
Revenue Next Year121.6%
Revenue Next 2Y87.6%
Revenue Next 3Y64.53%
Revenue Next 5Y48.09%
EBIT growth 1Y91.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year4402.44%
EBIT Next 3Y394.62%
EBIT Next 5Y226.16%
FCF growth 1Y36.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y209.58%
OCF growth 3YN/A
OCF growth 5YN/A